Christopher J. Sobecki, Director at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 25,595 shares at $2.38 ($65K) on 2019-09-16, disclosed to the SEC on 2019-09-17.
Open-market purchase of $65k LXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.38 | 200 | $476 | 0.7% |
| 2 | $2.40 | 800 | $2K | 2.9% |
| 3 | $2.41 | 300 | $723 | 1.1% |
| 4 | $2.43 | 500 | $1K | 1.9% |
| 5 | $2.45 | 200 | $490 | 0.8% |
| 6 | $2.46 | 1,400 |
| $3K |
| 5.3% |
| 7 | $2.47 | 2,500 | $6K | 9.5% |
| 8 | $2.48 | 3,300 | $8K | 12.5% |
| 9 | $2.48 | 100 | $249 | 0.4% |
| 10 | $2.49 | 100 | $249 | 0.4% |
| 11 | $2.49 | 1,784 | $4K | 6.8% |
| 12 | $2.50 | 1,151 | $3K | 4.4% |
| 13 | $2.51 | 776 | $2K | 3.0% |
| 14 | $2.52 | 295 | $742 | 1.1% |
| 15 | $2.52 | 295 | $743 | 1.1% |
| 16 | $2.52 | 1,405 | $4K | 5.4% |
| 17 | $2.52 | 100 | $253 | 0.4% |
| 18 | $2.53 | 100 | $253 | 0.4% |
| 19 | $2.53 | 820 | $2K | 3.2% |
| 20 | $2.54 | 100 | $254 | 0.4% |
| 21 | $2.54 | 800 | $2K | 3.1% |
| 22 | $2.54 | 100 | $254 | 0.4% |
| 23 | $2.55 | 400 | $1K | 1.6% |
| 24 | $2.56 | 900 | $2K | 3.5% |
| 25 | $2.57 | 900 | $2K | 3.5% |
| 26 | $2.58 | 100 | $258 | 0.4% |
| 27 | $2.59 | 200 | $518 | 0.8% |
| 28 | $2.60 | 791 | $2K | 3.2% |
| 29 | $2.73 | 1,478 | $4K | 6.2% |
| 30 | $2.75 | 3,700 | $10K | 15.6% |
| Total | $2.55 avg | 25,595 | $65K | 100% |
| Filing → |
| WTW | BUY | 2016-03-03 | $610K | — | Filing → |